Absorbable Heart Stents Pave the Way to a Market Size of US$ 822.7 Million by 2031 | Abbott Laboratories Arterial Remodeling Technologies B. Braun Melsungen AG Biotronik

Global Absorbable Heart Stent Market generated revenue of US$ 307.1 million in 2022 and is estimated to reach a valuation of US$ 822.7 million by 2031, growing at a CAGR of 12.02% during the forecast period from 2023 to 2031.

The demand for absorbable cardiac stents is poised to witness significant growth, driven by a multitude of pivotal factors. One such factor is the escalating prevalence of coronary artery disease, coupled with a corresponding surge in the number of percutaneous coronary intervention (PCI) procedures. Additionally, the market for absorbable heart stents is projected to expand owing to the implementation of healthcare reform initiatives by governments worldwide, as well as an increasing population of patients grappling with chronic illnesses. These factors collectively contribute to the promising outlook for the absorbable cardiac stents market, indicating a bright future ahead.

A Request of this Sample Report Here- https://www.astuteanalytica.com/request-sample/absorbable-heart-stent-market

The prevalence of coronary artery disease (CAD) is surging worldwide, establishing it as a leading cause of morbidity and mortality. According to the British Heart Foundation, coronary (ischaemic) heart disease is the most frequently diagnosed heart disease on a global scale, affecting approximately 200 million individuals. Of this number, around 110 million men and 80 million women are affected by coronary heart disease. This escalating prevalence of CAD has resulted in an increased demand for absorbable cardiac stents.

These stents are utilized in percutaneous coronary intervention (PCI) procedures, which have also witnessed a corresponding rise. The aging population, known to be more vulnerable to CAD and peripheral artery diseases, further fuels the demand for absorbable stents. Additionally, unhealthy lifestyle choices, insufficient physical activity, and the overall pervasiveness of cardiac conditions have contributed to the surge in CAD cases.

Unveiling the Future of Stents: Biodegradable Polymeric Heart Stents Paving the Way for Revolutionary Cardiac Care

In the ever-evolving landscape of cardiovascular medicine, biodegradable polymeric heart stents have emerged as a groundbreaking alternative to traditional metal stents. This innovative technology has witnessed a meteoric rise in demand, with over 43 million units of these stents sold worldwide in 2022.

The production and supply of these biodegradable stents are keeping pace with the growing demand. Medical device companies are actively investing in research, development, and production to meet the market's needs. As the technology continues to advance, manufacturing costs are expected to decrease, making these stents more affordable and accessible to patients.

The rising acceptance of biodegradable stents among patients and healthcare providers further fuels the market growth. These stents offer a multitude of advantages over their metal counterparts, including reduced risks of complications such as restenosis and thrombosis. Additionally, patients are no longer burdened with the need for long-term antiplatelet therapy. Biodegradable stents have been proven to promote natural healing and tissue regeneration, leading to improved patient outcomes in the absorbable heart stent market.

Surgeon preferences are also shifting towards biodegradable stents. Many surgeons favor these stents due to their ability to facilitate better vessel healing and maintain a more natural artery structure over time, thus minimizing the risk of complications.

As biodegradable polymeric heart stents continue to revolutionize cardiovascular treatment, the future looks promising. With their remarkable benefits and advancements in manufacturing, these stents are set to reshape the landscape of cardiac care, offering patients a safer and more effective alternative to traditional metal stents.

The Surge of Minimally Invasive Surgeries: A Paradigm Shift in Patient Care

In the realm of modern medicine, minimally invasive surgeries have emerged as a game-changer, offering a plethora of advantages that include reduced discomfort, fewer complications, and shorter hospital stays. These surgical techniques have now become widely adopted across various medical specialties, including cardiothoracic surgery, gastroenterology, gynecological surgery, cardiac surgery, pediatric surgery, urogynecology and pelvic reconstructive surgery, and urological surgery.

The World Health Organization (WHO) paints a stark reality, estimating that chronic diseases, including cardiovascular disease, will contribute to a staggering 1.5 million deaths in 2021 alone. Chronic illnesses, in general, account for a staggering 71% of all global deaths, with an estimated annual toll of 41 million lives lost.

With an increasing awareness of the benefits offered by minimally invasive techniques, the absorbable heart stents market is poised for substantial growth. Laparoscopic surgery, in particular, has gained remarkable popularity, further propelling the demand and advancements in this field.

As these techniques continue to evolve, the impact on patient outcomes and the overall healthcare landscape is bound to be profound. Embracing the era of minimally invasive surgeries promises a brighter future, where patients can experience enhanced recovery, reduced complications, and a renewed sense of hope in their journey toward wellness.

Unveiling the Global Surge: Asia Pacific, Europe, and North America Embrace Absorbable Cardiac Stents Market

In the realm of medical advancements, Asia Pacific emerges as the dominant region, boasting a market share of more than 35%. With cutting-edge technology at its disposal and benevolent reimbursement rules in place, this dynamic region generated a remarkable revenue of US$ 111.82 million in 2021. As the Asia Pacific region's economy continues to experience rapid expansion, the demand for medical equipment and treatments is on the rise, propelling the growth of this market.

The popularity of absorbable cardiac stents, which naturally dissolve over time in the body, is also gaining traction. As patients become more informed about the benefits of these innovative stents, significant growth is anticipated in Europe and North America as well. The United States, in particular, dominates the market with an impressive market share of approximately 25%.

For The Full Report, Please Follow This Link- https://www.astuteanalytica.com/industry-report/absorbable-heart-stent-market

The high prevalence of cardiovascular illnesses in the region necessitates stent treatments for a substantial patient population. With a staggering estimated 655,000 fatalities each year, cardiovascular disease stands as the leading cause of death in the United States, as acknowledged by the American Heart Association. Similarly, in Canada, cardiovascular disease ranks as the second-leading cause of mortality, responsible for approximately 20% of all fatalities.

The increasing demand for absorbable cardiac stents across these regions underscores the vital role they play in addressing the pressing healthcare needs of patients. As the world becomes more attuned to the potential of these innovative technologies, the global landscape of cardiovascular care is poised for a transformative shift. With Asia Pacific leading the charge, and Europe and North America following suit, the future holds great promise for improved patient outcomes, reduced complications, and a renewed sense of hope for those battling cardiovascular disease.

List of Key Companies Profiled:
Abbott Laboratories
Arterial Remodeling Technologies
B. Braun Melsungen AG
Biotronik
Boston Scientific Corporation
Elixir Medical Corporation
Kyoto Medical Planning
Medtronic
Meril Life Sciences Pvt. Ltd
Reva MedicalTerumo Medical Corporation
Lepu Medical Technology Co.
Other Prominent Players
Segmental Overview
By Material

Metallic Stents
Polymer Stents
By Absorption Rate

Slow absorption rate
Fast absorption rate
By Application

Coronary Artery Disease
Peripheral Artery Disease
By End User

Hospitals & Clinics
Cardiovascular Centers
Research Institutes & Organizations
Others
By Region

North America
The U.S.
Canada
Mexico
Europe
The U.K.
Germany
France
Italy
Spain
Poland
Russia
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia & New Zealand
ASEAN
Rest of Asia Pacific
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East & Africa

Get a Free Sample Report Here- https://www.astuteanalytica.com/request-sample/absorbable-heart-stent-market

About Astute Analytica

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.

𝐆𝐞𝐭 𝐢𝐧 𝐭𝐨𝐮𝐜𝐡 𝐰𝐢𝐭𝐡 𝐮𝐬

𝐏𝐡𝐨𝐧𝐞 𝐧𝐮𝐦𝐛𝐞𝐫: +𝟏𝟖𝟖𝟖𝟒𝟐𝟗𝟔𝟕𝟓𝟕

𝐄𝐦𝐚𝐢𝐥: sales@astuteanalytica.com

𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://www.astuteanalytica.com/

LinkedIn | Twitter | YouTube | Facebook

This release was published on openPR.